Ibandronate Sodium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

34 Suppliers, 14 USDMF, 2 CEP/COS, 1 JDMF, 7 EU WC, 24 KDMF, 5 NDC API, 19 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

191 Dossiers, 21 FDA Orange Book, 126 Europe, 1 Australia, 10 South Africa, 33 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - EQ 3MG BASE/3ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 31 Kerry, 22 BASF, 19 Roquette, 13 Microlex e.U, 11 Sigachi Industries, 10 Corel Pharma Chem, 10 Gangwal Healthcare, 8 Gangwal Chemicals, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Seppic, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 5 DFE Pharma, 5 Nanjing Well Pharmaceutical, 5 Actylis, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 SPI Pharma, 4 Prachin Chemical, 3 Kima Chemical, 3 Vasa Pharmachem, 3 Pharmatrans-Sanaq, 2 Nomisma Healthcare, 2 Seqens, 2 Finar, 2 Jai Radhe Sales, 2 The Dow Chemical Company, 2 DKSH, 1 Chynops Pharma, 1 Boai NKY Pharmaceuticals Ltd, 1 Clariant, 1 Alcedo Pharmachem, 1 Minakem, 1 Ingredion Pharma Solutions, 1 Zhejiang Huakang Pharmaceutical, 1 Ulanqab Kema New Material, 1 Aeon Procare, 1 ACG Worldwide, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 1 Shijiazhuang Huaxu Pharmaceutical, 1 NEWEDGE Overseas, 1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 31 Controlled & Modified Release, 24 Direct Compression, 23 Lubricants & Glidants, 22 Disintegrants & Superdisintegrants, 20 Film Formers & Plasticizers, 20 Thickeners and Stabilizers, 19 Granulation, 13 Solubilizers, 13 Topical, 12 Parenteral, 10 Co-Processed Excipients, 8 Taste Masking, 7 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Emulsifying Agents, 2 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

104 Finished Drug Prices

104 Finished Drug Prices

MARKET PLACE

5 APIs, 3 DOSSIERS // FDF

PATENTS

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 2 Others

DIGITAL CONTENT

6 News

6 News

Information, Expiry & Status of Health Canada Patents covering Ibandronate Sodium.

Ibandronate Sodium

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

34 Suppliers

14 USDMF

2 CEP/COS

1 JDMF

7 EU WC

24 KDMF

5 NDC API

19 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

191 Dossiers

21 FDA Orange Book

126 Europe

1 Australia

10 South Africa

33 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAVENOUS - EQ 3MG BASE/3ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

31 Kerry

22 BASF

19 Roquette

13 Microlex e.U

11 Sigachi Industries

10 Corel Pharma Chem

10 Gangwal Healthcare

8 Gangwal Chemicals

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Seppic

7 Ideal Cures Pvt Ltd

6 Lonza Capsugel

5 DFE Pharma

5 Nanjing Well Pharmaceutical

5 Actylis

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 SPI Pharma

4 Prachin Chemical

3 Kima Chemical

3 Vasa Pharmachem

3 Pharmatrans-Sanaq

2 Nomisma Healthcare

2 Seqens

2 Finar

2 Jai Radhe Sales

2 The Dow Chemical Company

2 DKSH

1 Chynops Pharma

1 Boai NKY Pharmaceuticals Ltd

1 Clariant

1 Alcedo Pharmachem

1 Minakem

1 Ingredion Pharma Solutions

1 Zhejiang Huakang Pharmaceutical

1 Ulanqab Kema New Material

1 Aeon Procare

1 ACG Worldwide

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

1 Shijiazhuang Huaxu Pharmaceutical

1 NEWEDGE Overseas

1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders

52 Coating Systems & Additives

TABLET;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 2.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INTRAVENOUS - EQ 3MG BASE/3ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons